Pacitti Group »

Werewolf Therapeutics shares owned by Pacitti Group

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Pacitti Group from 13F filings

Historical chart of Pacitti Group investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Pacitti Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Pacitti Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.6k 12k 0.63

More positions owned by Pacitti Group

Spdr Series Trust State Street Spd (BIL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
JPMorgan Chase & Co. (JPM)
Ishares Tr 10-20 Yr Trs Etf (TLH)
International Business Machines (IBM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Cardinal Health (CAH)
First Tr Exchange Traded Nasd Tech Div (TDIV)

View all positions for Pacitti Group

Top funds holding Werewolf Therapeutics

RA Capital Management
MPM Asset Management
Vanguard Group
MPM Oncology Impact Management
Renaissance Technologies
Lynx1 Capital Management
Sphera Funds Management
DC Funds
Partner Fund Management
Geode Capital Management
Millennium Management
Alyeska Investment Group
Jane Street
Citadel Advisors
State Street Corporation

View all funds holding Werewolf Therapeutics